Superworth

Teva Pharmaceutical Industries PE ratio TEVA

Share price divided by earnings per share over the last twelve months, since 2021.

Today, Nov 3, 2026
71.1×
5-year median
26.0×
Against its 5-year history
95th
percentile: 0 is its lowest day, 100 its highest
5-year range
12.1× to 70.2×
Peer median
46.5×

Teva Pharmaceutical Industries' PE ratio is 71.1× as of Nov 3, 2026: a share price of $42.95 against $0.60 of earnings per share over the last twelve months.

That is above its 5-year median of 26.0×, higher than on 95% of days in the last 5 years.

Over that time it ranged from 12.1× in Dec 2021 to 70.2× in Oct 2026.

The median for 10 healthcare stocks of a similar size is 46.5×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far67.8×23.2×70.2×
202553.1×40.0×53.1×
2024n/m a value too high to mean anything
2023n/m a value too high to mean anything
202222.9×12.6×27.4×
202112.1×12.1×14.4×

Against its peers

Companies in Healthcare nearest Teva Pharmaceutical Industries' size, closest first, today.

CompanyPE ratio
TEVATeva Pharmaceutical Industries71.1×
AAgilent Technologies34.5×
HUMHumana39.0×
MDLNMedlinen/m
WATWaters118×
IQVIQVIA32.0×
IDXXIDEXX Laboratories46.5×
EWEdwards Lifesciences54.5×
BDXBecton, Dickinson and59.9×
ONCBeOne Medicines63.2×
RPRXRoyalty Pharma38.2×
Peer median46.5×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Teva Pharmaceutical Industries

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.